Science 37 Holdings, Inc. (SNCE)

$2.24

+0.18 (+8.74%)
Rating:
Recommendation:
-
Symbol SNCE
Price $2.24
Beta 0.000
Volume Avg. 0.85M
Market Cap 259.573M
Shares () -
52 Week Range 1.61-15.103
1y Target Est -
DCF Unlevered SNCE DCF ->
DCF Levered SNCE LDCF ->
ROE -22.41% Sell
ROA -9.02% Neutral
Operating Margin -
Debt / Equity 33.94% Neutral
P/E -
P/B 1.48 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest SNCE news


Healthcare
Health Information Services
NASDAQ Global Market

Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.